 |
|
The use of 3 sugammadex out of 5 reversal of during recovery of rocuronium-induced neuromuscular blockade in a patient with post-tonsillectomy hemorrhage: a case report
Hee-Jong Lee, Kyo Sang Kim, Tae Yeon Kim, Jeoung Hyuk Lee, Miae Jeong
Korean J Anesthesiol. 2014;67(1):43-47. Published online 2014 Jul 29 DOI: https://doi.org/10.4097/kjae.2014.67.1.43
|
|
Citations to this article as recorded by
 Adverse events of sugammadex that occurred in a Korean population
Woong Han, Jong Min Lee, Dong Ho Park, Chia An Lee, Chang Yeong Jeong, Hong Seuk Yang
Anesthesia and Pain Medicine.2022; 17(2): 191. CrossRef Individual pharmacometric analysis for sugammadex reversal and re-administration of neuromuscular blockade
Yuki Kashima, Kenichi Masui
Journal of Anesthesia.2020; 34(5): 786. CrossRef Current use of neuromuscular blocking agents and antagonists in Korea: a 2018 survey
Jin Sun Kim, Jung Woo Han, Jae Ho Lee, Jae Moon Choi, Ha Jung Kim, Tae-Yun Sung, Yong Beom Kim, Yong Seop Shin, Hong Seuk Yang
Anesthesia and Pain Medicine.2019; 14(4): 441. CrossRef Feasibility of a ‘reversed’ isolated forearm technique by regional antagonization of rocuronium-induced neuromuscular block: a pilot study
T Hamp, M Mairweck, J Schiefer, M Krammel, E Pablik, M Wolzt, W Plöchl
British Journal of Anaesthesia.2016; 116(6): 797. CrossRef Repeat dosing of rocuronium-sugammadex: unpredictable
Yoon-Hee Kim
Korean Journal of Anesthesiology.2014; 67(1): 1. CrossRef
|